Carcinoid Cancer Foundation’s May 2011 Symposium Now Online

The Carcinoid Cancer Foundation is pleased to share with you videos from its carcinoid/NET symposium, “Neuroendocrine Tumor Management:  The Era of Personalized Medicine,” held on May 1, 2011 at Mt. Sinai Medical Center in New York City.

Following a welcome by Keith R.P. Warner, CEO of the Foundation, Dr. Richard R.P. Warner, Medical Director of the Carcinoid Cancer Foundation and Director of the Center for Carcinoid and Neuroendocrine Tumors at Mt. Sinai Hospital, gave Introductory Remarks.

The guest speakers were Dr. Edward M. Wolin, Co-Director of the Carcinoid and Neuroendocrine Tumor Program at Cedars-Sinai Medical Center in Los Angeles, and Dr. Eugene A. Woltering, The James D. Rives Professor of Surgery and Neurosciences at Louisiana State University Health Sciences Center in New Orleans, Louisiana.  Dr. Wolin spoke about “Carcinoid and NETs in 2011:  Now, New, Next” and the topic of Dr. Woltering’s lecture was “From the Bedside to the Laboratory and Back Again.”

A patient panel was presented and moderated by Gilles Frydman, founder of ACOR (Association of Cancer Online Resources) and a member of the Founding Circle, Society of Participatory Medicine.

Due to technical difficulties the question and answer period following Dr. Wolin’s presentation is not available in a video format but will be online in a written format shortly.

The symposium videos can be viewed here in order of the presentations:

  •  Keith R.P. Warner, Welcome
  • Richard R.P. Warner, MD, Introductory Remarks
  • Edward M. Wolin, MD, “Carcinoid and NETs in 2011:  Now, New, Next”
  • Eugene A. Woltering, MD, “From the Bedside to the Laboratory and Back Again”
  • Dr. Eugene Woltering, Questions and Answers
  • Patient Panel, presented and moderated by Gilles Frydman
Print Friendly
  • A million thanks to the Carcinoid Cancer Foundation for posting their recent symposium speakers to YouTube. I have forwarded the information to all of our support group members and whether you are new to neuroendocrine tumors or an old-timer, there is much to learn from these speakers. New developments and ways to manage this disease are always welcome, and the three W’s of NETs…Warner, Wolin and Woltering…once again deliver with the latest and greatest information! Thanks to all! Keep up the great work and know that those of us dealing with NETs carry a heartfelt appreciation for all you do on our behalf!
    Dianna Boomershine
    Heartland Carcinoid/NETs Support Group
    Columbia, MO

  • Thank you so much for your very kind words, Dianna! The Carcinoid Cancer Foundation is committed to bringing about greater awareness and education for the carcinoid/NET community and for the general public and medical professionals. With deepest appreciation to you and all support group leaders for what you do, every day, The CCF Team

  • great and extremely informative!!!!
    is it possible to get a description of KI-67,neurokinin A levels and chromogranne A is very difficult to copy this info from
    the video.

  • Hi Kenneth, we’re really glad the conference provided you with valuable information. Here’s a link to the Medical Glossary on the Foundation’s website: A letter written by our Medical Director, Richard R.P. Warner, MD, explains the unusual blood tests used routinely for NET cancer patients: We hope these resources are helpful. Please do not hesitate to contact us at 888-722-3132 (Eastern time) if we can be of further assistance.